z-logo
open-access-imgOpen Access
Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage
Author(s) -
Claudio Pozzi,
Francesca Ferrario,
Bianca Visciano,
Lucia Del Vecchio
Publication year - 2012
Publication title -
case reports in nephrology
Language(s) - English
Resource type - Journals
eISSN - 2090-6641
pISSN - 2090-665X
DOI - 10.1155/2012/180691
Subject(s) - medicine , proteinuria , renal function , nephropathy , renal biopsy , creatinine , lesion , corticosteroid , dialysis , gastroenterology , urology , kidney disease , biopsy , kidney , pathology , endocrinology , diabetes mellitus
Little is known about the utility of treating patients with advanced IgA nephropathy (IgAN). From 2001 to 2005, four patients came to our observation because of serum creatinine higher than 3 mg/dL, proteinuria ranging from 1.8 to 5.1 g/day, and a histological picture of diffuse sclerotic lesions. A corticosteroid course of 12 months was given. Patients were observed for a mean follow up of 84 months. At the end of the steroid course, proteinuria lowered quickly below 1 g/day in two patients, whereas the other two experienced a slower and less persistent decrease of proteinuria. Despite similar lesion severity at renal biopsy, renal function stabilized only in these two ones. In conclusion, these preliminary observations suggest a possible efficacy of corticosteroids in slowing down the progression of renal disease and in postponing the need of dialysis in IgAN patients with stage IV CKD and severe chronic histological lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom